Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 17, Issue 5, Pages 287-290
http://dx.doi.org/10.1155/2006/707296
AMMI Canada Annual Meeting Symposium

Where Have all the Antibiotics Gone?

Julian Davies

Department of Microbiology and Immunology, Life Sciences Institute, Vancouver, British Columbia, Canada

Copyright © 2006 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [66 citations]

The following is the list of published articles that have cited the current article.

  • Nicolle, “Beyond antibiotics?,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 17, no. 5, pp. 265–266, 2006. View at Publisher · View at Google Scholar
  • Holger Kock, Saraspadee Mootien, Mervyn Bibb, and Andy Hesketh, “The role of absC, a novel regulatory gene for secondary metabolism, in zinc-dependent antibiotic production in Streptomyces coelicolor A3(2),” Molecular Microbiology, vol. 74, no. 6, pp. 1427–1444, 2009. View at Publisher · View at Google Scholar
  • Russell Barlow, Thomas K. Hemscheidt, Domonkos Fehér, and Jesse McAtee, “Highly brominated antimicrobial metabolites from a marine Pseudoalteromonas sp.,” Journal of Natural Products, vol. 73, no. 11, pp. 1963–1966, 2010. View at Publisher · View at Google Scholar
  • Tianhong Dai, Ying-Ying Huang, Sulbha K. Sharma, Javad T. Hashmi, Divya B. Kurup, and Michael R. Hamblin, “Topical antimicrobials for burn wound infections,” Recent Patents on Anti-Infective Drug Discovery, vol. 5, no. 2, pp. 124–151, 2010. View at Publisher · View at Google Scholar
  • Diego Romero, Daniel López, Matthew F. Traxler, and Roberto Kolter, “Antibiotics as signal molecules,” Chemical Reviews, vol. 111, no. 9, pp. 5492–5505, 2011. View at Publisher · View at Google Scholar
  • Robert P. Rennie, “Current and Future Challenges in the Development of Antimicrobial Agents,” Antibiotic Resistance, vol. 211, pp. 45–65, 2012. View at Publisher · View at Google Scholar
  • Kenward Vong, Karine Auclair, Kenward Vong, and Karine Auclair, “Understanding and overcoming aminoglycoside resistance caused by N-6 '-acetyltransferase,” Medchemcomm, vol. 3, no. 4, pp. 397–407, 2012. View at Publisher · View at Google Scholar
  • Geraint B. Rogers, Mary P. Carroll, Kenneth D. Bruce, Geraint B. Rogers, Mary P. Carroll, and Kenneth D. Bruce, “Enhancing the utility of existing antibiotics by targeting bacterial behaviour?,” British Journal Of Pharmacology, vol. 165, no. 4, pp. 845–857, 2012. View at Publisher · View at Google Scholar
  • Robert P. Rennie, “Current and future challenges in the development of antimicrobial agents,” Handbook of Experimental Pharmacology, vol. 211, pp. 45–65, 2012. View at Publisher · View at Google Scholar
  • S. V. Rajmane, S. V. Pawar, R. H. Patil, P. G. More, N. N. Karale, A. S. Lawand, S. V. Rajmane, S. V. Pawar, R. H. Patil, P. G. More, N. N. Karale, and A. S. Lawand, “A 4-(o-methoxyphenyl)-2-aminothiazole: an anti-quorum sensing compound,” Medicinal Chemistry Research, vol. 22, no. 9, pp. 4183–4191, 2013. View at Publisher · View at Google Scholar
  • Kieron M. G. O'Connell, James T. Hodgkinson, Hannah F. Sore, Martin Welch, George P. C. Salmond, and David R. Spring, “Die Bekämpfung multiresistenter Bakterien: aktuelle Strategien zur Entdeckung neuer Antibiotika,” Angewandte Chemie, vol. 125, no. 41, pp. 10904–10932, 2013. View at Publisher · View at Google Scholar
  • Götz Haferburg, and Erika Kothe, “Activation of Silent Genes in Actinobacteria by Exploiting Metal Stress,” Actinobacteria, pp. 56–73, 2013. View at Publisher · View at Google Scholar
  • David.A. Phoenix, Sarah.R. Dennison, and Frederick Harris2013. View at Publisher · View at Google Scholar
  • David A. Phoenix, Sarah R. Dennison, and Frederick Harris, “Antimicrobial Peptides: Their History, Evolution, and Functional Promiscuity,” Antimicrobial Peptides, pp. 1–37, 2013. View at Publisher · View at Google Scholar
  • Kieron M. G. O'Connell, James T. Hodgkinson, Hannah F. Sore, Martin Welch, George P. C. Salmond, David R. Spring, Kieron M. G. O'Connell, James T. Hodgkinson, Hannah F. Sore, Martin Welch, George P. C. Salmond, and David R. Spring, “Combating Multidrug-Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials,” Angewandte Chemie-International Edition, vol. 52, no. 41, pp. 10706–10733, 2013. View at Publisher · View at Google Scholar
  • Erika Kothe, and Götz Haferburgpp. 56–73, 2013. View at Publisher · View at Google Scholar
  • Steve P. Bernier, and Michael G. Surette, “Concentration-dependent activity of antibiotics in natural environments,” Frontiers in Microbiology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Richard J. Fair, Lisa S. McCoy, Mary E. Hensler, Bernice Aguilar, Victor Nizet, Yitzhak Tor, Richard J. Fair, Lisa S. McCoy, Mary E. Hensler, Bernice Aguilar, Victor Nizet, and Yitzhak Tor, “Singly Modified Amikacin and Tobramycin Derivatives Show Increased rRNA A-Site Binding and Higher Potency against Resistant Bacteria,” Chemmedchem, vol. 9, no. 9, pp. 2164–2171, 2014. View at Publisher · View at Google Scholar
  • Eilis C. Bragginton, and Laura J.V. Piddock, “UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: An observational study,” The Lancet Infectious Diseases, vol. 14, no. 9, pp. 857–868, 2014. View at Publisher · View at Google Scholar
  • Francisco Pimenta, Lúcia Chaves Simões, Ana Cristina Abreu, and Manuel Simões, “What should be considered in the treatment of bacterial infections by multi-drug therapies: A mathematical perspective?,” Drug Resistance Updates, vol. 17, no. 3, pp. 51–63, 2014. View at Publisher · View at Google Scholar
  • Wendy W. K. Mok, and Yingfu Li, “Therapeutic peptides: New arsenal against drug resistant pathogens,” Current Pharmaceutical Design, vol. 20, no. 5, pp. 771–792, 2014. View at Publisher · View at Google Scholar
  • Dirk Schnappinger, “Genetic approaches to facilitate antibacterial drug development,” Cold Spring Harbor Perspectives in Medicine, vol. 5, no. 7, 2015. View at Publisher · View at Google Scholar
  • Hansa Y. Done, Arjun K. Venkatesan, and Rolf U. Halden, “Does the Recent Growth of Aquaculture Create Antibiotic Resistance Threats Different from those Associated with Land Animal Production in Agriculture?,” AAPS Journal, vol. 17, no. 3, pp. 513–524, 2015. View at Publisher · View at Google Scholar
  • Eduardo Asín-Prieto, Alicia Rodríguez-Gascón, and Arantxazu Isla, “Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents,” Journal of Infection and Chemotherapy, 2015. View at Publisher · View at Google Scholar
  • Gashaw M. Goshu, Debarati Ghose, Joy M. Bain, Phillip G. Pierce, Darren W. Begley, Stephen N. Hewitt, Hannah S. Udell, Peter J. Myler, R. Meganathan, and Timothy J. Hagen, “Synthesis and biological evaluation of pyrazolopyrimidines as potential antibacterial agents,” Bioorganic & Medicinal Chemistry Letters, vol. 25, no. 24, pp. 5699–5704, 2015. View at Publisher · View at Google Scholar
  • Rajmohan Rajamuthiah, Eleftherios Mylonakis, Hiwa Majed, Wooseong Kim, Beth Burgwyn Fuchs, Frederick M. Ausubel, Elamparithi Jayamani, Annie L. Conery, Bumsup Kwon, and Michael J. Kelso, “Antibacterial properties of 3-(phenylsulfonyl)-2-pyrazinecarbonitrile,” Bioorganic and Medicinal Chemistry Letters, vol. 25, no. 22, pp. 5203–5207, 2015. View at Publisher · View at Google Scholar
  • Anne Wibaux, Priyaleela Thota, Daniel L. Prince, Neal Carty, Peter Johnson, and Jozef Mastej, “Antimicrobial activity of a novel vascular access film dressing containing chlorhexidine gluconate,” PLoS ONE, vol. 10, no. 11, 2015. View at Publisher · View at Google Scholar
  • Siouxsie Wiles, “All models are wrong, but some are useful: Averting the ‘microbial apocalypse’,” Virulence, vol. 6, no. 8, pp. 730–732, 2015. View at Publisher · View at Google Scholar
  • Evren Doruk Engin, “Tryptophan Metabolites: A Microbial Perspective,” Tryptophan Metabolism: Implications for Biological Processes, Health and Disease, pp. 75–94, 2015. View at Publisher · View at Google Scholar
  • Isabel T. Carvalho, and Lúcia Santos, “Antibiotics in the aquatic environments: A review of the European scenario,” Environment International, vol. 94, pp. 736–757, 2016. View at Publisher · View at Google Scholar
  • Gashaw Mamo, “Anaerobes as Sources of Bioactive Compounds and Health Promoting Tools,” 2016. View at Publisher · View at Google Scholar
  • Jiuyu Liu, Richard E. Lee, Daniel T. Hoagland, and Robin B. Lee, “New agents for the treatment of drug-resistant Mycobacterium tuberculosis,” Advanced Drug Delivery Reviews, vol. 102, pp. 55–72, 2016. View at Publisher · View at Google Scholar
  • Hannah Landecker, “Antibiotic Resistance and the Biology of History,” Body & Society, vol. 22, no. 4, pp. 19–52, 2016. View at Publisher · View at Google Scholar
  • Philipp Klahn, and Mark Brönstrup, “New structural templates for clinically validated and novel targets in antimicrobial drug research and development,” Current Topics in Microbiology and Immunology, vol. 398, pp. 365–417, 2016. View at Publisher · View at Google Scholar
  • Kathrin I. Mohr, “History of Antibiotics Research,” 2016. View at Publisher · View at Google Scholar
  • David A. Phoenix, Sarah R. Dennison, and Frederick Harrispp. 161–204, 2016. View at Publisher · View at Google Scholar
  • Julia Revuelta, Eduardo García-Junceda, Montserrat Latorre, and Agatha Bastida, “6-O-Nucleotidyltransferase: An aminoglycoside-modifying enzyme specific for streptomycin/streptidine,” MedChemComm, vol. 7, no. 1, pp. 177–183, 2016. View at Publisher · View at Google Scholar
  • Yssel, Vanderleyden, and Steenackers, “Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitors,” Journal of Antimicrobial Chemotherapy, vol. 72, no. 8, pp. 2326–2333, 2017. View at Publisher · View at Google Scholar
  • Daniely M. Silva, Eulina Maria N. Menezes, Emerson V. Silva, and Thaís A.C. Lamounier, “Prevalence and antimicrobial susceptibility profile of ESKAPE pathogens from the Federal District, Brazil,” Jornal Brasileiro de Patologia e Medicina Laboratorial, vol. 53, no. 4, pp. 240–245, 2017. View at Publisher · View at Google Scholar
  • Josep M Sierra, Ester Fusté, Teresa Vinuesa, Francesc Rabanal, and Miguel Viñas, “An overview of antimicrobial peptides and the latest advances in their development,” Expert Opinion on Biological Therapy, vol. 17, no. 6, pp. 663–676, 2017. View at Publisher · View at Google Scholar
  • Christopher M. Crittenden, Zachary B. Jenner, Martín Gonzalez, Jennifer S. Brodbelt, and Kerry A. Bruns, “Hydrocarbon-stapled lipopeptides exhibit selective antimicrobial activity,” Biopolymers, vol. 108, no. 3, 2017. View at Publisher · View at Google Scholar
  • Evan Martens, and Arnold L. Demainpp. 149–168, 2017. View at Publisher · View at Google Scholar
  • P. Klahn, and M. Brönstrup, “Bifunctional antimicrobial conjugates and hybrid antimicrobials,” Nat. Prod. Rep., 2017. View at Publisher · View at Google Scholar
  • Caio Barros, Stephanie Fulaz, Danijela Stanisic, and Ljubica Tasic, “Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB),” Antibiotics, vol. 7, no. 3, pp. 69, 2018. View at Publisher · View at Google Scholar
  • Agata Wozniak, and Mariusz Grinholc, “Combined Antimicrobial Activity of Photodynamic Inactivation and Antimicrobials–State of the Art,” Frontiers in Microbiology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Sara Travaglione, Alessia Fabbri, Zaira Maroccia, Stefano Loizzo, Claudio Frank, and Carla Fiorentini, “New therapeutics from Nature: The odd case of the bacterial cytotoxic necrotizing factor 1,” Biomedicine and Pharmacotherapy, vol. 101, pp. 929–937, 2018. View at Publisher · View at Google Scholar
  • R R Bragg, C M Meyburgh, J-Y Lee, and M Coetzee, “Potential Treatment Options in a Post-antibiotic Era,” Infectious Diseases and Nanomedicine III, vol. 1052, pp. 51–61, 2018. View at Publisher · View at Google Scholar
  • Ward, and N Ee Allenby, “Genome mining for the search and discovery of bioactive compounds: The Streptomyces paradigm,” FEMS Microbiology Letters, vol. 365, no. 24, 2018. View at Publisher · View at Google Scholar
  • Elizabeth G. A. Fredheim, Vidar Sørum, Daniel E. Rozen, Nicole L. Podnecky, Julia Kloos, Raul Primicerio, Adam P. Roberts, Ørjan Samuelsen, and Pål J. Johnsen, “Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli,” Nature Communications, vol. 9, no. 1, 2018. View at Publisher · View at Google Scholar
  • Preeti Chaturvedi, Raja Aadil Hussain Bhat, and Amit Pande, “Antimicrobial peptides of fish: innocuous alternatives to antibiotics,” Reviews in Aquaculture, 2018. View at Publisher · View at Google Scholar
  • Laura Carro, “Protein-protein interactions in bacteria: A promising and challenging avenue towards the discovery of new antibiotics,” Beilstein Journal of Organic Chemistry, vol. 14, pp. 2881–2896, 2018. View at Publisher · View at Google Scholar
  • N. Dane Scott, and N. Dane Scott, “Magic Bullets II, Genetic Engineering and Technological Pragmatism,” Food, Genetic Engineering and Philosophy of Technology, vol. 28, pp. 59–78, 2018. View at Publisher · View at Google Scholar
  • Uzma Shabir, Sajad Ali, Parveena Firdous, Toyeeba Hassan, Aqib Rehman Magray, Bashir Ahmad Ganai, and Ruqeya Nazir, “Fish antimicrobial peptides (AMP's) as essential and promising molecular therapeutic agents: A review,” Microbial Pathogenesis, vol. 114, pp. 50–56, 2018. View at Publisher · View at Google Scholar
  • F. Jerry Reen, Gerard P. McGlacken, Eoin Ó Muimhneacháin, and Fergal O'Gara, “Analogues of Pseudomonas aeruginosa signalling molecules to tackle infections,” Organic and Biomolecular Chemistry, vol. 16, no. 2, pp. 169–179, 2018. View at Publisher · View at Google Scholar
  • Adrian Hutchings, and Ian Edwin Cock, “An interactive antimicrobial activity of embelica officinalis gaertn. Fruit extracts and conventional antibiotics against some bacterial triggers of autoimmune inflammatory diseases,” Pharmacognosy Journal, vol. 10, no. 4, pp. 654–662, 2018. View at Publisher · View at Google Scholar
  • Etthel M. Windels, Joran E. Michiels, Bram Van den Bergh, Maarten Fauvart, and Jan Michiels, “Antibiotics: Combatting Tolerance To Stop Resistance,” mBio, vol. 10, no. 5, 2019. View at Publisher · View at Google Scholar
  • Julia E. Grimwade, and Alan C. Leonard, “Blocking the Trigger: Inhibition of the Initiation of Bacterial Chromosome Replication as an Antimicrobial Strategy,” Antibiotics, vol. 8, no. 3, pp. 111, 2019. View at Publisher · View at Google Scholar
  • Pavithra Ilanko, Pauline Ann McDonnell, Sandy van Vuuren, and Ian Edwin Cock, “Interactive antibacterial profile of Moringa oleifera Lam. extracts and conventional antibiotics against bacterial triggers of some autoimmune inflammatory diseases,” South African Journal of Botany, vol. 124, pp. 420–435, 2019. View at Publisher · View at Google Scholar
  • Susanne A. Kraemer, Arthi Ramachandran, and Gabriel G. Perron, “Antibiotic Pollution in the Environment: From Microbial Ecology to Public Policy,” Microorganisms, vol. 7, no. 6, pp. 180, 2019. View at Publisher · View at Google Scholar
  • Shipra Shah, and Jahangeer A. Bhat, “Ethnomedicinal knowledge of indigenous communities and pharmaceutical potential of rainforest ecosystems in Fiji Islands,” Journal of Integrative Medicine, 2019. View at Publisher · View at Google Scholar
  • Esaú López-Jácome, Rafael Franco-Cendejas, Héctor Quezada, Rosario Morales-Espinosa, Israel Castillo-Juárez, Bertha González-Pedrajo, Ana María Fernández-Presas, Arturo Tovar-García, Vanesa Angarita-Zapata, Paula Licona-Limón, Mariano Martínez-Vázquez, and Rodolfo García-Contreras, “The race between drug introduction and appearance of microbial resistance. Current balance and alternative approaches,” Current Opinion in Pharmacology, vol. 48, pp. 48–56, 2019. View at Publisher · View at Google Scholar
  • Libang Liang, Amanda Sproule, Brad Haltli, Douglas H. Marchbank, Fabrice Berrué, David P. Overy, Kate McQuillan, Martin Lanteigne, Noelle Duncan, Hebelin Correa, and Russell G. Kerr, “Discovery of a New Natural Product and a Deactivation of a Quorum Sensing System by Culturing a “Producer” Bacterium With a Heat-Killed “Inducer” Culture,” Frontiers in Microbiology, vol. 9, 2019. View at Publisher · View at Google Scholar
  • Wontae Hwang, and Sang Sun Yoon, “Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar
  • Thomas M. Wood, and Nathaniel I. Martin, “The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry,” MedChemComm, 2019. View at Publisher · View at Google Scholar
  • Heidi Pauer, Thaís Glatthardt, Nicole V. Ferreira, Rosana B.R. Ferreira, and L. Caetano M. Antunes, “Bioactive Molecules of the Human Microbiome,” Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications, pp. 115–125, 2019. View at Publisher · View at Google Scholar
  • Des Raj Kashyap, “Microbial Metabolites: Peptides of Diverse Structure and Function,” New and Future Developments in Microbial Biotechnology and Bioengineering, pp. 87–101, 2019. View at Publisher · View at Google Scholar